SCHEMBL2321894

SCHEMBL2321894

Clc1cccc(Nc2nccc(-c3ccnc(CN4CCCCC4)c3)n2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMK2D Q13557 6/20 0.67
CDK2 P24941 5/20 0.59
CDK1 P06493 3/20 0.59
SMG1 Q96Q15 3/20 0.59
CSNK2A1 P68400 2/20 0.58
MAPT P10636 2/20 0.56
MTOR P42345 2/20 0.56
CDK4 P11802 2/20 0.56
NPC1 O15118 1/20 0.56
CCNT1 O60563 1/20 0.56
CCNB1 P14635 1/20 0.56
XBP1 P17861 1/20 0.56
CCNA2 P20248 1/20 0.56
CCND1 P24385 1/20 0.56
CCNE1 P24864 1/20 0.56
MAPK1 P28482 1/20 0.56
HTT P42858 1/20 0.56
CDK7 P50613 1/20 0.56
CDK9 P50750 1/20 0.56
RAB9A P51151 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2321985 0.82 CAMK2D (0.67) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL2328299 0.82 CSNK2A1 (0.69) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL2324895 0.82 MAPT (0.66) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL2322029 0.82 CDK2 (0.67) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL2325239 0.78 MAPT (0.61) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL3513778 0.78 CAMK2D (0.73) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL5733933 0.77 CAMK2D (0.71) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL4899574 0.76 ABL1 (0.76) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL5629076 0.76 CSNK2A1 (0.74) CAMK2DCDK2CDK1SMG1CSNK2A1
SCHEMBL5732902 0.76 CAMK2D (0.77) CAMK2DCDK2CDK1SMG1CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110294810-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS BAYER CROPSCIENCE AG (DE) 2011-12-01 US disclosed
CN-102216286-A Substituted (pyridyl)-azinylamine derivatives as plant protection agents BAYER CROPSCIENCE SA 2011-10-12 CN disclosed
EP-2356102-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS Bayer CropScience AG (DE) 2011-08-17 EP disclosed
WO-2010055114-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS BAYER CROPSCIENCE SA (FR) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294810-A1 SUBSTITUTED (PYRIDYL)-AZINYLAMINE DERIVATIVES AS PLANT PROTECTION AGENTS PRXL2A, AZI2, PIR CAMK2D 4279/4885CDK2 1282/4885CDK1 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.